Edible Vaccine Market
Edible Vaccines Industry Outlook to 2028 & 2033: Worldwide Revenues Set to Reach $12.5 Billion by 2028
December 11, 2024 07:06 ET | Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Edible Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The edible vaccine market size has grown strongly in...
Dengue Vaccine Market
Growth Trends in the Dengue Vaccines Industry, 2024-2028 & 2033
December 11, 2024 05:04 ET | Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Dengue Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The dengue vaccine market size has grown rapidly in...
mRNA Vaccines and Therapeutics Market
mRNA Vaccines and Therapeutics Industry Forecast to Generate Over $72 Billion in Revenues by 2032 - Breakdown by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region
December 11, 2024 04:18 ET | Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines and Therapeutics Market by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region 2024-2032" report has...
EVAXION_DEEPBLUE_RGB.png
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
December 02, 2024 08:00 ET | Evaxion Biotech
COPENHAGEN, Denmark, December 2, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present...
Global Meningococcal Vaccine Market
$14.58 Bn Meningococcal Vaccines Market Assessment (2023-2034) by Type, Brand, Age Group, Serotype, End-user and Region
November 26, 2024 11:53 ET | Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccine Market by Type, by Brand, by Age Group, by Serotype, by End-user, and by Region" report has been added to ...
Intranasal Drug and Vaccine Delivery Market
Intranasal Drug and Vaccine Delivery Market Research Report 2025-2030: Multi-dose Intranasal Systems Excel, Offering Convenience and Reduced Need for Refills
November 25, 2024 09:50 ET | Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and...
cmi_logo.png
[Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 21, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Membrane Filtration Market Size, Trends and Insights By Product...
Human Papillomavirus (HPV) Vaccine Market
Human Papillomavirus (HPV) Vaccines Industry, Forecast to 2032 - HPV Vaccine Market Set to Nearly Triple by 2032 as U.S. & Europe Lead; Japan & India Emerge as Key Growth Regions
November 07, 2024 09:33 ET | Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccine Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The human...
U.S. Influenza Vaccines Market
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts 2019-2023 & 2024-2033
October 29, 2024 10:59 ET | Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to...
bw-logo-enfold-1.png
BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
October 28, 2024 08:05 ET | BlueWillow Biologics
ANN ARBOR, Mich., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of intranasal vaccines, today announced that the company will...